Trualt Bioenergy Ltd

Trualt Bioenergy Ltd has announced that its Board of Directors will convene on July 28, 2026. The primary agenda item for this meeting is to consider and approve the unaudited standalone and consolidated financial results for the quarter ending June 30, 2026. In line with SEBI regulations, the trading window for company securities will remain closed for designated persons and their immediate relatives until 48 hours after the submission of these financial results to the stock exchanges. The company will also host this disclosure on its official website.

Trualt Bioenergy Ltd has announced the closure of its trading window for equity shares. The window will be shut from July 1, 2026, and will reopen 48 hours after the submission of the company's unaudited financial results for the first quarter ended June 30, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The specific date for the board meeting to approve these financial results will be communicated later.

TruAlt Bioenergy has received approval for ₹150 crore in financial assistance under the PM JI-VAN Yojana for its Sustainable Aviation Fuel (SAF) project. This funding, approved by the Centre for High Technology (CHT), is expected to cover 7-10% of the project's capital expenditure. The project aims to produce 10 crore litres of SAF annually, supporting India's energy transition, aviation decarbonization, and reducing reliance on imported fossil fuels. This initiative aligns with global and domestic SAF blending targets and positions India as a competitive SAF producer.

TruAlt Bioenergy Limited has received approval for ₹150 crore in financial assistance under the Government of India's PM JI-VAN Yojana for its proposed commercial-scale Sustainable Aviation Fuel (SAF) project in Bagalkot, Karnataka. The approval, granted by the Centre for High Technology (CHT) under the Ministry of Petroleum & Natural Gas, is a significant step in the company's expansion into advanced biofuels. This funding is expected to cover 7-10% of the project's capital expenditure, enhancing its viability. The SAF facility, with a planned production capacity of 10 crore litres per annum, aims to advance India's energy transition, aviation decarbonization, and reduce dependence on imported fossil fuels, aligning with India's SAF blending targets of 1% by 2027, 2% by 2028, and 5% by 2030.

Trualt Bioenergy Ltd has announced its financial results for the quarter and year ended March 31, 2026. Key highlights include revenue from operations of ₹1704.65 lakhs for the year ended March 31, 2026, compared to ₹1880.11 lakhs in the previous year. The Board approved the audited standalone and consolidated financial results and also approved the appointment of M/s ZADN and Associates LLP as Internal Auditors and M/s R. Nanabhoy & Co. as Cost Auditors for the financial year 2026-27.

Trualt Bioenergy Ltd's board approved the appointment of M/s ZADN and Associates LLP as Internal Auditors and M/s R. Nanabhoy & Co. as Cost Auditors for the financial year 2026-27. This decision was made based on the recommendation of the Audit Committee during a meeting held on May 22, 2026. The board also approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, along with the auditor's report by M/s N. M. Raiji & Co.

Trualt Bioenergy Ltd's board approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The company reported revenue from operations of ₹1704.65 million and a net profit of ₹80.03 million for the fiscal year. The board also approved the appointment of M/s ZADN and Associates LLP as Internal Auditors and M/s R. Nanabhoy & Co. as Cost Auditors for the financial year 2026-27.

Trualt Bioenergy Ltd has scheduled a Board of Directors meeting on May 22, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The trading window for the company's securities remains closed for designated persons and their immediate relatives until 48 hours after the results are submitted to the stock exchanges. The disclosure will be available on the company's website.

Trualt Bioenergy Ltd has submitted a Monitoring Agency Report by Crisil Ratings Limited for the quarter ended March 31, 2026, in compliance with SEBI regulations regarding the utilization of IPO proceeds. The report indicates no deviations from the stated objectives of the IPO. Crisil Ratings monitored gross proceeds of ₹750.00 crore, noting issue expenses of ₹92.96 crore and net proceeds of ₹657.04 crore. The company's IPO took place from September 25, 2025, to September 29, 2025.

Trualt Bioenergy Ltd has designated Mr. Monu Kumar, Company Secretary and Compliance Officer, to determine the materiality of events or information as per the SEBI Listing Regulations. This decision was made in a Board of Directors meeting on March 30th, 2026. The list of Key Managerial Personnel has been updated accordingly.